» Articles » PMID: 29215273

Marine Natural Product Honaucin A Attenuates Inflammation by Activating the Nrf2-ARE Pathway

Overview
Journal J Nat Prod
Date 2017 Dec 8
PMID 29215273
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The cyanobacterial marine natural product honaucin A inhibits mammalian innate inflammation in vitro and in vivo. To decipher its mechanism of action, RNA sequencing was used to evaluate differences in gene expression of cultured macrophages following honaucin A treatment. This analysis led to the hypothesis that honaucin A exerts its anti-inflammatory activity through activation of the cytoprotective nuclear erythroid 2-related factor 2 (Nrf2)-antioxidant response element/electrophile response element (ARE/EpRE) signaling pathway. Activation of this pathway by honaucin A in cultured human MCF7 cells was confirmed using an Nrf2 luciferase reporter assay. In vitro alkylation experiments with the natural product and N-acetyl-l-cysteine suggest that honaucin A activates this pathway through covalent interaction with the sulfhydryl residues of the cytosolic repressor protein Keap1. Honaucin A presents a potential therapeutic lead for diseases with an inflammatory component modulated by Nrf2-ARE.

Citing Articles

The Neuroprotective Role of Cyanobacteria with Focus on the Anti-Inflammatory and Antioxidant Potential: Current Status and Perspectives.

Rodrigues F, Reis M, Ferreira L, Grosso C, Ferraz R, Vieira M Molecules. 2024; 29(20).

PMID: 39459167 PMC: 11510616. DOI: 10.3390/molecules29204799.


Isolation and Characterization of the Cyanobacterial Macrolide Glycoside Moorenaside, an Anti-Inflammatory Analogue of Aurisides Targeting the Keap1/Nrf2 Pathway.

Al-Awadhi F, Kokkaliari S, Ratnayake R, Paul V, Luesch H J Nat Prod. 2024; 87(10):2355-2365.

PMID: 39315953 PMC: 11519913. DOI: 10.1021/acs.jnatprod.4c00420.


Discovery and Anti-Inflammatory Activity of a Cyanobacterial Fatty Acid Targeting the Keap1/Nrf2 Pathway.

Al-Awadhi F, Simon E, Liu N, Ratnayake R, Paul V, Luesch H Mar Drugs. 2023; 21(11).

PMID: 37999377 PMC: 10672429. DOI: 10.3390/md21110553.


Naturally Occurring Organohalogen Compounds-A Comprehensive Review.

Gribble G Prog Chem Org Nat Prod. 2023; 121:1-546.

PMID: 37488466 DOI: 10.1007/978-3-031-26629-4_1.


Lead/Drug Discovery from Natural Resources.

Xu Z, Eichler B, Klausner E, Duffy-Matzner J, Zheng W Molecules. 2022; 27(23).

PMID: 36500375 PMC: 9736696. DOI: 10.3390/molecules27238280.


References
1.
Kwak M, Huang B, Chang H, Kim J, Kensler T . Tissue specific increase of the catalytic subunits of the 26S proteasome by indirect antioxidant dithiolethione in mice: enhanced activity for degradation of abnormal protein. Life Sci. 2007; 80(26):2411-20. DOI: 10.1016/j.lfs.2007.04.014. View

2.
Liu Y, Kern J, Walker J, Johnson J, Schultz P, Luesch H . A genomic screen for activators of the antioxidant response element. Proc Natl Acad Sci U S A. 2007; 104(12):5205-10. PMC: 1829287. DOI: 10.1073/pnas.0700898104. View

3.
Ali R, Rattan S . Curcumin's biphasic hormetic response on proteasome activity and heat-shock protein synthesis in human keratinocytes. Ann N Y Acad Sci. 2006; 1067:394-9. DOI: 10.1196/annals.1354.056. View

4.
Kibble M, Saarinen N, Tang J, Wennerberg K, Makela S, Aittokallio T . Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat Prod Rep. 2015; 32(8):1249-66. DOI: 10.1039/c5np00005j. View

5.
Ong S, Li X, Schenone M, Schreiber S, Carr S . Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC. Methods Mol Biol. 2011; 803:129-40. DOI: 10.1007/978-1-61779-364-6_9. View